Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia
Author(s) -
Tze Pin Ng,
Liang Feng,
Ma Shwe Zin Nyunt,
Lei Feng,
Qi Gao,
May Lim,
Simon L. Collinson,
Mei Sian Chong,
Wee Shiong Lim,
Tih Shih Lee,
Philip Yap,
Keng Bee Yap
Publication year - 2016
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2015.4899
Subject(s) - dementia , medicine , hazard ratio , metabolic syndrome , dyslipidemia , diabetes mellitus , prospective cohort study , incidence (geometry) , cognitive decline , population , cohort study , obesity , confidence interval , endocrinology , disease , physics , environmental health , optics
The association of the metabolic syndrome (MetS) and component cardiovascular risk factors with the risk of developing mild cognitive impairment (MCI) and MCI progression to dementia is not well established.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom